The crude cumulative incidence rates of AD and ADRD were comparable in those who received angiotensin-II stimulating antihypertensive medications (4.3% and 21.7%) and those receiving angiotensin-II inhibiting medications (4.2% and 23.5%). This evidence concerns the gene AGT and Alzheimer disease.